Assessment of Atrioventricular and Ventriculoarterial Coupling Indices in Patients with Hypoplastic Left Heart Syndrome Utilizing Cardiac MRI and Invasive Hemodynamics

In the complex world of congenital heart defects, some conditions require the body to rebuild its own plumbing from the ground up. Hypoplastic left heart syndrome is one such condition, where the left side of the heart, which normally pumps blood to the entire body, is too small to function. In these patients, the right ventricle, which usually handles only the lungs, must take on the heavy burden of circulating blood everywhere. To survive, these children undergo a series of surgeries that reroute blood flow, eventually connecting the veins from the upper body directly to the lungs, bypassing the heart entirely. This final stage, known as the Fontan procedure, relies on a delicate balance: the single working ventricle must fill with blood efficiently from the atrium and then push it out against the resistance of the body's arteries. If this balance is off, the system can fail, leading to heart failure, the need for a transplant, or other serious complications.

For decades, doctors have tried to predict which patients will struggle with this new arrangement by looking at how well the heart muscle squeezes or how much blood it holds. However, the heart is a machine of moving parts that work together, and looking at just one part often misses the bigger picture. Researchers have long studied "coupling," a concept that describes how well two connected parts of a system work in sync. In a healthy heart, the atrium and ventricle fill and empty in a coordinated rhythm, and the ventricle pushes against the arteries with just the right amount of force. When these connections break down, the heart struggles. While this idea has been tested in many types of heart disease, it had never been applied to the unique, single-ventricle physiology of hypoplastic left heart syndrome patients waiting for their final surgery.

A team of researchers at the University of Colorado set out to fill this gap by looking back at the medical records of forty-five patients with hypoplastic left heart syndrome who were preparing for their Fontan procedure. These patients had undergone a specific type of imaging called cardiac magnetic resonance, which creates detailed, moving pictures of the heart, as well as invasive catheterization, where a thin tube is used to measure pressures inside the heart and blood vessels. The researchers wanted to see if specific measurements of how well the heart's chambers and arteries worked together could predict who would face adverse outcomes, such as death, the need for a heart transplant, or hospitalization for heart failure. They compared patients who experienced these bad outcomes against those who did not, looking for differences in how the heart's parts were interacting.

The study found that the traditional ways of measuring heart performance were not very helpful for this specific group of patients. The researchers tested several established formulas that measure the relationship between the right atrium and the right ventricle, but these numbers did not clearly separate the patients who did well from those who did not. It appears that the standard tools used for other heart conditions do not translate well to the distorted anatomy of a single-ventricle heart. However, the team also developed two new ways of measuring these relationships, designed specifically for the unique flow of blood in these patients. These new indices looked at how much blood the atrium pumped into the ventricle relative to the size of the ventricle, and how that combined with the ventricle's ability to push blood into the body's main artery.

The results were striking. The patients who later experienced adverse outcomes had significantly lower scores on these new, custom-designed tests compared to those who remained healthy. One of the new measures, which looked at the efficiency of the atrium filling the ventricle, showed a clear difference between the two groups, with the struggling patients having much lower values. Another combined measure, which linked the atrium, the ventricle, and the main artery into a single score, was even better at distinguishing between the two groups. In fact, adding these new measurements to the existing data improved the ability to predict bad outcomes significantly. The study suggests that while the old methods of checking heart function might miss the warning signs in these patients, these new, tailored measurements can spot the early signs of trouble.

The researchers also confirmed that the patients who had worse outcomes showed other signs of heart stress, such as lower pumping efficiency and higher pressures in the blood vessels leading to the lungs. But the key discovery was that the new coupling indices provided a clearer picture of the risk than any single measurement of heart size or strength alone. By capturing the entire chain of blood flow—from the atrium, through the ventricle, and out to the body—these new tools offer a more complete view of the heart's health. While the study was limited by its small size and the fact that it looked at past data, the findings point toward a new way of monitoring these fragile patients. The authors conclude that these novel indices, which are built for the specific needs of single-ventricle physiology, may help doctors identify high-risk patients earlier, potentially allowing for better timing of interventions before the system fails.